﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/syngene-collaborates-with-johns-hopkins-university-to-advance-early-stage-drug-discovery-19087</loc><lastmod>2026-02-11T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/wockhardt-reports-strong-q3-growth-revenue-up-22-ebitda-surges-72-19088</loc><lastmod>2026-02-11T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/apollo-hospitals-reports-robust-q3-earnings-profit-after-tax-humps-to-rs-3835-million-19089</loc><lastmod>2026-02-11T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/iambic-taps-ai-to-power-multi-year-drug-discovery-deal-with-takeda-19090</loc><lastmod>2026-02-11T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/veradermics-completes-enrollment-in-both-phase-3-male-hair-loss-trials-19091</loc><lastmod>2026-02-11T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>